Clinical Trial Update: Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial of topotecan in young patients with neoplastic meningitis due to leukemia, lymphoma, or solid tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Neoplasms
• Leukemia
• Lymphoma

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: Pediatric Brain Tumor Consortium | Conditions: Brain and Central Nervous System Tumors, Carcinoma of Unknown Primary | Phase 1 | Status: TERMINATED